<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Malaria</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->

      <h1>Malaria</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>


        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
        <br>

        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>Malaria</strong> is the most important parasitic disease of <strong>human beings</strong>.</li>
                <li>Malaria is a <strong>protozoan disease</strong> transmitted by <strong>Anopheles mosquitoes</strong>.</li>
                <li>Five species of the genus <strong>Plasmodium</strong> cause all <strong>malarial infections</strong> in <strong>human beings</strong>.</li>
                <li>Most cases are caused by either <strong>Plasmodium falciparum</strong> (<strong>SSA</strong>) or <strong>Plasmodium vivax</strong> (<strong>Other regions</strong>), but human infections can also be caused by <strong>Plasmodium ovale</strong>, <strong>Plasmodium malariae</strong>, and, in parts of southeast Asia, the monkey malaria <strong>Plasmodium knowlesi</strong>.</li>
            </ul>
            
            <h4>What is Malaria?</h4>
            <ul>
                <li><strong>Malaria</strong> is caused by the parasite of the genus <strong>Plasmodium</strong>.</li>
                <li>Five species of <strong>plasmodium</strong> cause infection in humans:</li>
                <ul>
                    <li><strong>P. falciparum</strong> - Most common/deadly</li>
                    <li><strong>P. vivax</strong></li>
                    <li><strong>P. ovale</strong></li>
                    <li><strong>P. malariae</strong></li>
                    <li><strong>P. knowlesi</strong></li>
                </ul>
            </ul>

<br>
            <table class="note-table">
                <tr>
                    <th colspan="2">Plasmodium Species</th>
                </tr>
                <tr>
                    <td><strong>Falciparum</strong></td>
                    <td>
                        <p>Commonest in Africa (98% of malaria)</p>
                        <p>Main cause of severe malaria</p>
                        <p><strong>Rapidly fatal</strong></p>
                    </td>
                </tr>
                <tr>
                    <td><strong>Vivax</strong></td>
                    <td>
                        <p>Responsible for half of malaria cases outside Africa</p>
                        <p>Contributes to malaria in horn of Africa</p>
                        <p>Can cause severe malaria</p>
                        <p><strong>Relapse occurs</strong></p>
                    </td>
                </tr>
                <tr>
                    <td><strong>Ovale</strong></td>
                    <td>
                        <p>Mostly occurs in sub-Sahara Africa</p>
                        <p>Incidence relatively low</p>
                        <p>Not associated with fatal disease</p>
                        <p><strong>Relapse occurs</strong></p>
                    </td>
                </tr>
                <tr>
                    <td><strong>Malariae</strong></td>
                    <td>
                        <p>Distribution is everywhere</p>
                        <p>Tends to occur as mixed infection</p>
                        <p>Replication is slow</p>
                        <p>Hence parasitaemia is very low</p>
                    </td>
                </tr>
                <tr>
                    <td><strong>Knowlesi</strong></td>
                    <td>
                        <p>Occurs as a zoonotic infection</p>
                        <p>Difficult to differentiate from trophozoites of P. malariae</p>
                        <p>Causes severe malaria and rapidly fatal</p>
                        <p>As rule consider P. knowlesi if there is microscopic suggestion of P. malariae with high parasitaemia</p>
                    </td>
                </tr>
            </table>
            
            
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Transmission</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>Bites from infected female Anopheles mosquito</strong></li>
                <ul>
                    <li>The main method of transmission</li>
                    <li>Bites occur between dusk and dawn</li>
                </ul>
                <li><strong>Accidental</strong></li>
                <ul>
                    <li>Blood transfusion, needle stick injury</li>
                </ul>
                <li><strong>Mother to Child</strong></li>
                <ul>
                    <li>1 in 20 mothers could infect their babies if they have malaria close to delivery</li>
                </ul>
                <li><strong>Animal to Man</strong></li>
                <ul>
                    <li>From close interaction with the Macaques</li>
                </ul>
            </ul>
            

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Epidemiology of Malaria</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>91 countries and territories</li>
                <li>Half <strong>world at risk</strong> (<strong>3.4 billion</strong>)</li>
                <li>According to the latest <strong>WHO</strong> estimates, released in December 2017, there were <strong>216 million cases</strong> of malaria in 2016 and <strong>445,000 deaths</strong></li>
                <li>The <strong>malaria mortality rate</strong>, which takes into account <strong>population growth</strong>, is estimated to have decreased by <strong>60%</strong> globally between <strong>2000</strong> and <strong>2015</strong></li>
            </ul>
            

            <h4>Classification on Transmission Rates</h4>
            <ul>
                <li><strong>High transmission</strong> (>1 case per 1000 pop)</li>
                <ul>
                    <li>Transmission is all year round, but there may be seasonal variation.</li>
                    <li>Partial immunity in older children and adults.</li>
                    <li>May be less likely to get severe disease.</li>
                </ul>
                <li><strong>Low transmission</strong> (<1 case per 1000 population)</li>
                <ul>
                    <li>Intermittent transmission that may be annual, bi-annual, or variable.</li>
                    <li>Prone to occurrence of malaria epidemics.</li>
                </ul>
                <li><strong>Malaria Free</strong> (Zero cases)</li>
                <ul>
                    <li>Usually the population has no immunity whatsoever against malaria and</li>
                    <li>therefore prone to severe malaria if they travel to high transmission areas.</li>
                </ul>
            </ul>
            
            <h4>Classification based on Spleen and Parasite Rates</h4>
            <ul>
                <li>The spleen rate % enlarged spleens in a sample of the population, usually children aged 2‚Äì10 years.</li>
                <li>The <strong>parasite rate</strong> is the proportion of a given population with malaria parasites in the blood.</li>
                <li>According to the classification using these two indices, regions may be described as:</li>
                <ul>
                    <li><strong>Hypoendemic:</strong> Spleen and parasite rates 1‚Äì10%</li>
                    <li><strong>Mesoendemic:</strong> Spleen and parasite rates 11‚Äì50%</li>
                    <li><strong>Hyperendemic:</strong> Spleen and parasite rates constantly > 50%</li>
                    <li><strong>Holoendemic:</strong> Spleen and parasite rates constantly > 75% (for parasite rate this applies to infants only)</li>
                </ul>
            </ul>
            
            <h4>Determinants of Endemicity</h4>
            <ul>
                <li>Presence of competent <strong>Anopheles mosquitoes</strong></li>
                <li>Human factors, especially socio-economic factors, and control measures</li>
                <li><strong>Temperature</strong>:</li>
                <ul>
                    <li>Sporogony phase requires temperature between <strong>16¬∞C and 33¬∞C</strong> and mean relative humidity of <strong>60%</strong></li>
                </ul>
            </ul>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Malaria Life Cycle </a>
          </h2>
        </header>
        <div class='body'>



                        
            
                                                  <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/malaria (1).jpg" alt="" onclick="openModal(this)">
                            <div class="caption">Malaria Life Cycle </div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption">Malaria Life Cycle </div>
                          </div>

                        <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/malaria (1).png" alt="" onclick="openModal(this)">
                            <div class="caption">Malaria Life Cycle (3-sites, 3-steps, 1 or 2-exit)</div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption">Malaria Life Cycle (3-sites, 3-steps, 1 or 2-exit)</div>
                          </div>


                        <!-- image here -->
                        <div class="image-container">
                            <img src="../figures/malaria (2).jpg" alt="" onclick="openModal(this)">
                            <div class="caption">P. falciparum ‚Äì asexual stages</div>
                          </div>
                          
                          <div id="myModal" class="modal">
                            <span class="close" onclick="closeModal()">&times;</span>
                            <img class="modal-content" id="modalImage">
                            <div id="caption" class="caption">P. falciparum ‚Äì asexual stages</div>
                          </div>

                          
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Classification of Malaria</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>Uncomplicated Malaria</strong>:</li>
                <ul>
                    <li>Symptomatic infection with malaria parasitaemia without evidence of vital organ dysfunction</li>
                    <li><strong>Symptoms:</strong></li>
                    <ul>
                        <li>The main manifestation is <strong>FEVER</strong></li>
                        <li>Cold Chills / Rigor</li>
                        <li>Headaches and other body aches</li>
                        <li>Malaise</li>
                        <li>Nausea / Vomiting</li>
                        <li>Joint weakness / pains</li>
                    </ul>
                    <li><strong>Signs:</strong></li>
                    <ul>
                        <li>Fever</li>
                        <li>Hepatosplenomegaly</li>
                        <li>Pallor (Children / pregnant women)</li>
                    </ul>
                </ul>
                <li><strong>Severe Malaria</strong></li>
                <ul>
                    <li>Acute falciparum malaria with evidence of vital organ dysfunction. Or,</li>
                    <li>Patient with P. falciparum asexual parasitaemia and presence of one or more of the clinical or laboratory features listed.</li>
                </ul>
            </ul>

<br>
            <table class="note-table">
                <tr>
                    <th colspan="2">
                        Severe Malaria- WHO 2015
                    </th>
                </tr>
                <tr>
                    <td><strong>Impaired consciousness</strong></td>
                    <td>A Glasgow coma score < 11 in adults or a Blantyre coma score < 3 in children</td>
                </tr>
                <tr>
                    <td><strong>Prostration</strong></td>
                    <td>Generalized weakness so that the person is unable to sit, stand or walk without assistance</td>
                </tr>
                <tr>
                    <td><strong>Multiple convulsions</strong></td>
                    <td>More than two episodes within 24 h</td>
                </tr>
                <tr>
                    <td><strong>Acidosis</strong></td>
                    <td>A base deficit of > 8 mEq/L or, if not available, a plasma bicarbonate level of < 15 mmol/L or venous plasma lactate ‚â• 5 mmol/L. Severe acidosis manifests clinically as respiratory distress (rapid, deep, laboured breathing).</td>
                </tr>
                <tr>
                    <td><strong>Hypoglycaemia</strong></td>
                    <td>Blood or plasma glucose < 2.2 mmol/L (< 40 mg/dL)</td>
                </tr>
                <tr>
                    <td><strong>Severe malarial anaemia</strong></td>
                    <td>Haemoglobin concentration ‚â§ 5 g/dL or a haematocrit of ‚â§ 15% in children < 12 years of age (< 7 g/dL and < 20%, respectively, in adults) with a parasite count > 10,000/¬µl</td>
                </tr>
                <tr>
                    <td><strong>Renal impairment</strong></td>
                    <td>Plasma or serum creatinine > 265 Œºmol/L (3 mg/dL) or blood urea > 20 mmol/L</td>
                </tr>
                <tr>
                    <td><strong>Jaundice</strong></td>
                    <td>Plasma or serum bilirubin > 50 Œºmol/L (3 mg/dL) with a parasite count > 100,000/¬µL</td>
                </tr>
                <tr>
                    <td><strong>Pulmonary oedema</strong></td>
                    <td>Radiologically confirmed or oxygen saturation < 92% on room air with a respiratory rate > 30/min, often with chest in-drawing and crepitation on auscultation</td>
                </tr>
                <tr>
                    <td><strong>Significant bleeding</strong></td>
                    <td>Including recurrent or prolonged bleeding from the nose, gums or venepuncture sites; haematemesis or melena</td>
                </tr>
                <tr>
                    <td><strong>Shock</strong></td>
                    <td>Compensated shock is defined as capillary refill ‚â• 3 s or temperature gradient on leg (mid to proximal limb), but no hypotension. Decompensated shock is defined as systolic blood pressure < 70 mm Hg in children or < 80 mmHg in adults, with evidence of impaired perfusion (cool peripheries or prolonged capillary refill).</td>
                </tr>
                <tr>
                    <td><strong>Hyperparasitaemia</strong></td>
                    <td>P. falciparum parasitaemia > 10%</td>
                </tr>
            </table>
            
            
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Who is at Risk for Malaria?</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>Children</strong></li>
                <li><strong>Pregnant Women</strong></li>
                <li><strong>Adults</strong></li>
                <li><strong>Everyone</strong></li>
            </ul>
            
            <h4>Groups at Special Risk</h4>
            <ul>
                <li>People who are heavily exposed to the bites of mosquitoes infected with <strong>P. falciparum</strong>.</li>
                <li>People who have little or no immunity to malaria, such as <strong>young children</strong> and <strong>pregnant women</strong>.</li>
                <li>Travelers coming from areas with no malaria are more likely to become very sick and die.</li>
            </ul>
            
            <h4>Groups at Special Risk</h4>
            <ul>
                <li>Poor people living in rural areas who lack access to health care are at greater risk for this disease.</li>
                <li>People suffering from <strong>Sickle Cell Anaemia</strong> (Not SCD)</li>
                <li>Refugees or Internally Displaced Persons</li>
                <li>Those who have had their <strong>spleens removed</strong></li>
            </ul>
            
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Clinical Assessment </a>
          </h2>
        </header>
        <div class='body'>
           
            <section id='heading-7-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-1'>History</a>
                  </h3>
                </header>
                <div class='body'>
                    <h4>General Information</h4>
                    <ul>
                        <li><strong>Age</strong>, <strong>place of residence</strong>, and <strong>travel</strong>.</li>
                    </ul>
                    
                    <h4>Specific Features of Uncomplicated Disease</h4>
                    <ul>
                        <li><strong>Fever</strong>, <strong>chills / rigor</strong>,</li>
                        <li><strong>Headaches</strong> and other aches in the older patient</li>
                    </ul>
                    
                    <h4>Ask About</h4>
                    <ul>
                        <li>Features of severe disease</li>
                        <li>Previous treatment with <strong>antimalarial drug</strong></li>
                    </ul>
                    
    
                </div>
              </section>

              <section id='heading-7-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-2'>Physical Examination</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>Check <strong>body temperature</strong>.</li>
                        <li><strong>Pallor</strong> (children/pregnant women)</li>
                        <li>Check <strong>state of hydration</strong></li>
                        <li><strong>Pulse</strong> and <strong>BP</strong></li>
                        <li>Enlarged <strong>spleen</strong> or <strong>liver</strong>, especially in children</li>
                    </ul>
                    
                    <h4>Exclude Signs of Severe Disease:</h4>
                    <ul>
                        <li>Central nervous system:</li>
                        <ul>
                            <li>Assess the level of consciousness using an objective <strong>coma scale</strong></li>
                            <li>Evidence of <strong>Seizure</strong></li>
                            <li><strong>Posturing</strong></li>
                            <li><strong>Fundoscopy</strong></li>
                        </ul>
                        <li>Respiratory system: check for <strong>respiratory distress</strong></li>
                        <li>Cardiovascular: rate, volume of pulse, BP</li>
                        <li>Abdomen: Feel for the spleen and liver</li>
                        <li>Identifying other possible causes of disease.</li>
                    </ul>
                    
                    
    
                </div>
              </section>

              <section id='heading-7-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-3'>Diagnosis</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li><strong>Clinical</strong></li>
                        <ul>
                            <li><strong>Fever</strong> + other symptoms</li>
                            <li>Exclusion of focal point of disease</li>
                            <li>Endemicity</li>
                        </ul>
                        <li><strong>Parasitological</strong></li>
                        <ul>
                            <li>Required to confirm diagnosis in all patients</li>
                            <li>To monitor response to treatment/treatment failure</li>
                        </ul>
                        <li><strong>Other Tests</strong></li>
                        <ul>
                            <li>HCT, Blood glucose,</li>
                            <li>Lumbar Puncture</li>
                        </ul>
                    </ul>
                    
                    <section id='heading-7-3-1'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-7-3-1'>Laboratory Diagnosis- Microscopy</a>
                          </h4>
                        </header>
                        <div class='body'>
                            <ul>
                                <li>Involves staining and direct visualization of the parasite under the microscope.</li>
                                <li>Peripheral smear study on light microscopy using various stains</li>

                                <ul>
                                    <li><strong>Thick blood film</strong></li>
                                    <li><strong>Thin blood films</strong></li>
                                </ul>

                                            <!-- image here -->
                            <div class="image-container">
                                <img src="../figures/malaria (3).jpg" alt="" onclick="openModal(this)">
                                <div class="caption">Thin and thick smear</div>
                            </div>
                            
                            <div id="myModal" class="modal">
                                <span class="close" onclick="closeModal()">&times;</span>
                                <img class="modal-content" id="modalImage">
                                <div id="caption" class="caption">Thin and thick smear</div>
                            </div>
                                <li><strong>Quantitative Buffy Coat test (QBC)</strong></li>
                            </ul>
                            
                            <h4>Light Microscopy ‚Äì Thick Blood Film</h4>
                            <ul>
                                <li><strong>Parasite identification</strong></li>
                                <li><strong>Parasite density</strong></li>
                            </ul>

                                        <!-- image here -->
            <div class="image-container">
                <img src="../figures/malaria (4).jpg" alt="" onclick="openModal(this)">
                <div class="caption">Light Microscopy ‚Äì Thick Blood Film</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Light Microscopy ‚Äì Thick Blood Film</div>
              </div>
                            
                            <h4>Light Microscopy ‚Äì Thin Blood Film</h4>
                            <ul>
                                <li><strong>Speciation</strong></li>
                                <li><strong>Parasite Density</strong></li>
                            </ul>
                            
                                        <!-- image here -->
            <div class="image-container">
                <img src="../figures/malaria (5).jpg" alt="" onclick="openModal(this)">
                <div class="caption">Light Microscopy ‚Äì Thin Blood Film</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Light Microscopy ‚Äì Thin Blood Film</div>
              </div>

              <h4>Quantitative Buffy Coat test (QBC)</h4>
              <ul>
                <li>Blood is mixed with acridine orange</li>
                <li>Centrifuge in a capillary tube</li>
                <li>Read directly with a fluorescent microscope</li>
              </ul>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/malaria (3).png" alt="" onclick="openModal(this)">
                <div class="caption">QBC</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">QBC</div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/malaria (4).png" alt="" onclick="openModal(this)">
                <div class="caption">QBC</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">QBC</div>
              </div>
                
                        </div>
                      </section>

                      <section id='heading-7-3-2'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-7-3-2'>Non-Microscopic Tests</a>
                          </h4>
                        </header>
                        <div class='body'>

                            <ul>
                                <li>Involves identification of the <strong>parasitic antigen</strong> or the <strong>anti-plasmodial antibodies</strong> or the parasitic metabolic products.</li>
                                <li><strong>RDTs</strong></li>
                                <li><strong>PfHRPII antigens</strong></li>
                                <li><strong>pLDH enzyme</strong></li>
                                <li><strong>Other Tests</strong></li>
                                <ul>
                                    <li><strong>Polymerase Chain Reaction</strong></li>
                                    <li>Detection of antibodies by <strong>Radioimmunoassay</strong>, <strong>immunofluorescence</strong>, or <strong>enzyme immunoassay</strong>.</li>
                                </ul>
                            </ul>

                            <h4>Rapid Diagnostic Tests</h4>
                            <ul>
                                <li>Detects specific antigens (proteins) produced by malaria parasites</li>
                                <li>These antigens are present in the blood of infected or recently infected people.</li>
                                <li>The RDT signifies their presence by a colour change on nitrocellulose strip</li>

            <!-- image here -->
            <div class="image-container">
                <img src="../figures/malaria (6).jpg" alt="" onclick="openModal(this)">
                <div class="caption">RDTs Detects specific antigens (proteins) produced by malaria parasites</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="captRDTs ion">Detects specific antigens (proteins) produced by malaria parasites</div>
              </div>

                                                            
                            <h4>RDT: PfHRP-2 Based Test</h4>
                            <ul>
                                <li>This is a dip stick antigen capture assay, using a monoclonal antibody against <strong>P. falciparum histidine-rich protein-2 (PfHRP-2)</strong></li>

                            </ul>
                                        <!-- image here -->
            <div class="image-container">
                <img src="../figures/malaria (7).jpg" alt="" onclick="openModal(this)">
                <div class="caption">RDT: PfHRP-2 Based Test</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">RDT: PfHRP-2 Based Test</div>
              </div>
                            <h4>RDTs: pLDH Based Test</h4>
                            <ul>
                                <li>Dip stick coated with monoclonal antibodies against the intracellular metabolic enzyme parasite lactate dehydrogenase (pLDH)</li>
                                <li>Allows for speciation between the pLDH isoforms.</li>
                                <li>pLDH is produced only by live parasites,</li>
                                <li>Hence the ability to differentiate live from dead organisms</li>
                            </ul>
                            </ul>

                            

                                        <!-- image here -->
            <div class="image-container">
                <img src="../figures/malaria (8).jpg" alt="" onclick="openModal(this)">
                <div class="caption">RDTs: pLDH Based Test</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">RDTs: pLDH Based Test</div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/malaria (2).png" alt="" onclick="openModal(this)">
                <div class="caption">Malaria Diagnosis -</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">RDTs</div>
              </div>
                            
                        </div>
                      </section>
    
                </div>
              </section>

              
              <section id='heading-7-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-4'>Treatment of Malaria</a>
                  </h3>
                </header>
                <div class='body'>

                    <br>

                    <table class="note-table">
                        <tr>
                            <th colspan="4">Principles of Antimalarial Treatment</th>
                        </tr>
                        <tr>
                            <th>Aims</th>
                            <th>Causation</th>
                            <th>Therapy</th>
                            <th>Drugs</th>
                        </tr>
                        <tr>
                            <td>To alleviate symptoms</td>
                            <td>Symptoms are caused by blood forms of the parasite</td>
                            <td>Blood schizonticidal drugs</td>
                            <td>Chloroquine, quinine, pyrimethamine/sulphadoxine, artemisinin and its derivatives</td>
                        </tr>
                        <tr>
                            <td>To prevent relapse</td>
                            <td>Relapses due to hypnozoites of P. vivax/P. ovale</td>
                            <td>Tissue schizonticidal drugs</td>
                            <td>Primaquine</td>
                        </tr>
                        <tr>
                            <td>To prevent spread</td>
                            <td>Spread is through the gametocytes</td>
                            <td>Gametocytocidal drugs</td>
                            <td>Primaquine for P. falciparum, Chloroquine for all others</td>
                        </tr>
                    </table>
                    
                    <h4>Uncomplicated Malaria</h4>
                    <ul>
                        <li><strong>Artemether-lumefantrine</strong></li>
                        <ul>
                            <li>1.5/9 mg/kg twice daily for three days</li>
                        </ul>
                        <li><strong>Artesunate-Amodiaquine</strong></li>
                        <ul>
                            <li>Artesunate 4 mg/kg + Amodiaquine 10mg base/kg once daily for 3 days</li>
                        </ul>
                        <li><strong>Artesunate+Mefloquine</strong></li>
                        <ul>
                            <li>Artesunate 4 mg/kg once daily for 3 days + mefloquine 25 mg base/kg (mefloquine 8.3mg/kg daily for 3 days)</li>
                        </ul>
                        <li><strong>Artesunate+Sulfadoxine/pyrimethamine</strong></li>
                        <ul>
                            <li>Artesunate 4mg/kg once daily for 3 days + SP 25/1.25mg/kg once</li>
                        </ul>
                        <li><strong>Dihydroartemisinin+piperaquine</strong></li>
                        <ul>
                            <li>In children &lt;25kg 2.5mg/kg DHA and 20mg/kg PPQ once daily for 3 days</li>
                        </ul>
                        <li><strong>New</strong></li>
                        <ul>
                            <li><strong>Pyronaridine-Artesunate</strong></li>
                            <ul>
                                <li>Granules and Tablets</li>
                            </ul>
                        </ul>
                    </ul>
                    

                    <h4>What is Antimalarial Combination Therapy</h4>
                    <ul>
                        <li>Simultaneous use of two or more blood schizonticidal drugs with</li>
                        <ul>
                            <li>Independent modes of action and</li>
                            <li>Different biochemical targets in the parasite</li>
                        </ul>
                        <li>Fixed-dose formulations or co-administrated therapy</li>
                    </ul>
                    
    
                </div>
              </section>

              
              <section id='heading-7-5'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-5'>Management of Severe Malaria</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                        <li>This comprises of four main steps:</li>
                        <ul>
                            <li><strong>Clinical assessment</strong> of the patient,</li>
                            <li><strong>Specific anti-malarial treatment</strong>,</li>
                            <li><strong>Treatment of complications</strong>, and</li>
                            <li><strong>Supportive care</strong>.</li>
                        </ul>
                    </ul>
                    
                    <h4>Clinical Assessment</h4>
                    <ul>
                        <li>Rapid evaluation</li>
                        <li>To make a clinical diagnosis of severe malaria</li>
                        <li>Identify life-threatening complications</li>
                    </ul>
                    
                    <section id='heading-7-5-1'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-7-5-1'>Treatment of Severe Malaria</a>
                          </h4>
                        </header>
                        <div class='body'>
                            <ul>
                                <li>For children ‚â§20kg, <strong>artesunate 3 mg/kg BW</strong> IV or IM given on admission (time = 0), then at 12 h and 24 h, then once a day is the recommended treatment.</li>
                                <li>For adults and children >20kg, <strong>artesunate 2.4 mg/kg Body Weight (BW)</strong> IV or IM given on admission (time = 0), then at 12 h and 24 h, then once a day is the recommended treatment.</li>
                                <li>There is no upper limit to the total dose of artesunate.</li>
        
                                <li>Artemether, or quinine, is an acceptable alternative if parenteral artesunate is not available:</li>
                                <ul>
                                    <li><strong>Artemether 3.2 mg/kg BW</strong> IM given on admission then 1.6mg/kg BW per day; or</li>
                                    <li><strong>Quinine 20 mg salt/kg BW</strong> on admission (IV infusion or divided IM injection), then 10 mg/kg BW every 8 hrs;</li>
                                </ul>
                                <li>Parenteral antimalarials used in the treatment of severe malaria should be given for a minimum of 24 hours, once started (irrespective of the patient's ability to tolerate oral medication earlier), and, thereafter, complete treatment a full course of the recommended ACT.</li>
                            </ul>
                            
                            <p>At community or health facility levels where complete management of severe malaria is not possible, patients with severe malaria should be given pre-referral treatment and referred immediately to an appropriate facility for further treatment.</p>
                            <p>The following options for pre-referral treatment are recommended in a ranked order:</p>
                            <ul>
                                <li>For children: <strong>artesunate IM;</strong> <strong>rectal artesunate;</strong> <strong>artemether IM;</strong> <strong>quinine IM</strong></li>
                                <li>For adults: <strong>artesunate IM,</strong> <strong>artemether IM;</strong> <strong>quinine IM</strong></li>
                            </ul>
                
                        </div>
                      </section>

                      <section id='heading-7-5-2'>
                        <header>
                          <h4>
                
                            <a aria-hidden href='#heading-7-5-2'>Treatment of Complications & Supportive Care</a>
                          </h4>
                        </header>
                        <div class='body'>
                            <ul>
                                <li>Coma (cerebral malaria):</li>
                                <ul>
                                    <li>Standard care for the unconscious patient</li>
                                    <li>Avoid harmful ancillary treatment such as <strong>corticosteroids, heparin</strong>, and <strong>adrenaline</strong>; intubate if necessary</li>
                                </ul>
                                <li>Hyperpyrexia:</li>
                                <ul>
                                    <li>Tepid sponging, fanning, cooling blanket, and <strong>antipyretic drugs</strong></li>
                                </ul>
                                <li>Convulsions:</li>
                                <ul>
                                    <li>Maintain airways; treat promptly with intravenous or rectal <strong>benzodiazepine</strong> or intramuscular <strong>paraldehyde</strong></li>
                                </ul>

                                <li>Hypoglycaemia:</li>
                                <ul>
                                    <li>Correct hypoglycaemia and maintain with glucose-containing infusion</li>
                                </ul>
                                <li>Severe anaemia:</li>
                                <ul>
                                    <li>(Hb <5g%, or PCV <15%) Transfuse</li>
                                </ul>
                                <li>Acute pulmonary oedema:</li>
                                <ul>
                                    <li>Prop up at 45¬∞, give oxygen, give diuretic, stop intravenous fluids, intubate and add PEEP/CPAP in life-threatening hypoxaemia; haemofilter</li>
                                </ul>
                                <li>Acute renal failure:</li>
                                <ul>
                                    <li>Exclude pre-renal causes, check fluid balance, urinary sodium; if in established renal failure; haemofilter or haemodialysis, or if unavailable, peritoneal dialysis.</li>
                                </ul>
                                <li>Spontaneous bleeding and coagulopathy:</li>
                                <ul>
                                    <li>Transfuse screened fresh whole blood (cryoprecipitate, /fresh frozen plasma and platelets if available; vitamin K injection</li>
                                </ul>
                                <li>Metabolic acidosis:</li>
                                <ul>
                                    <li>Exclude or treat hypoglycaemia, hypovolaemia and septicaemia.</li>
                                </ul>
                                <li>Shock:</li>
                                <ul>
                                    <li>Suspect septicaemia, make blood cultures; give parenteral antimicrobials, correct haemodynamic disturbances.</li>
                                </ul>
                                <li>Hyperparasitaemia:</li>
                                <ul>
                                    <li>>250,000 parasites per Œºl of blood.</li>
                                </ul>
                            </ul>
                            
                
                        </div>
                      </section>


                    
    
                </div>
              </section>
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'> Control of Malaria</a>
          </h2>
        </header>
        <div class='body'>
            <h4>WHAT IS RBM?</h4>
            <ul>
                <li>A global movement mobilizing support for local initiative</li>
                <li>A coordinated approach to strengthen public and private health care.</li>
                <li>Multiple strategies targeted to meet local malaria control needs.</li>
                <li>A diverse partnership acting in concert to achieve common goals.</li>
                <li>Established 31st July 1998</li>
            </ul>
            
            <h4>Six Principles of RBM</h4>
            <ul>
                <li>Early detection</li>
                <li>Rapid diagnosis and Effective Treatment</li>
                <li>Multiple prevention</li>
                <li>Focused research</li>
                <li>Well coordinated actions</li>
                <li>Dynamic movement</li>
            </ul>
            

            <h4>1. Early Detection</h4>
            <ul>
                <li>Community Awareness</li>
                <ul>
                    <li>Grassroots education and training to facilitate early detection of illness</li>
                </ul>
                <li>Surveillance</li>
                <ul>
                    <li>And climate studies to detect at-risk groups.</li>
                </ul>
                <li>Resistance Alert</li>
                <ul>
                    <li>Drug resistance pattern will guide prescription to ensure effective treatment.</li>
                </ul>
            </ul>
            
            <h4>2. Rapid Diagnosis And Effective Treatment</h4>
            <ul>
                <li>Home is the First Hospital</li>
                <ul>
                    <li>A simple packet of fast-acting drugs made widely available to parents can rescue children before it is too late.</li>
                </ul>
                <li>Bringing Treatment to the People</li>
                <ul>
                    <li>People with fever often seek help from friends or local healers. Communities must become knowledgeable in treating malaria quickly.</li>
                </ul>
            </ul>
            


            <h4>3. Multiple Prevention</h4>
            <ol>
                <li>
                    <h5>Integrated Vector Management (IVM)</h5>
                    <ol type="a">
                        <li>The use of <strong>Long Lasting Insecticidal Nets (LLINs)</strong></li>
                        <li>Indoor Residual Spraying (IRS)</li>
                        <li>Larval Source Management (Larviciding and Environmental Management)</li>
                        <li>Personal protective measures such as house screening, durable linings and the use of repellents</li>
                    </ol>
                </li>
                <li>
                    <h5>Malaria Chemoprevention</h5>
                    <ol type="a">
                        <li>Chemoprophylaxis for non-immune immigrants & at risk groups</li>
                        <li>Intermittent Preventive Treatment</li>
                        <li>Seasonal Malaria Chemoprevention</li>
                        <li>?Vaccine</li>
                    </ol>
                </li>
            </ol>
            
            <p><strong>Intermittent Preventive Treatment (IPT)</strong></p>
            <ul>
                <li>All pregnant women should receive two doses of IPT after quickening, during routinely scheduled ANC visits but no more frequently than monthly (as Directly observed Treatment)</li>
                <li>Presently, the most effective drug for IPT is <strong>sulfadoxine-pyrimethamine (SP)</strong></li>
            </ul>
            
            <p><strong>Timing Of IPT And Fetal Growth Velocity</strong></p>
            
            <p>IPT is best given when the fetal growth velocity is at its highest, in order to reduce placental parasitaemia and resultant fetal growth retardation</p>
            

            <h4>4. Focused Research</h4>
            <ul>
                <li>Drive to discover new tools</li>
                <li>A new medicine has to be discovered every 5 years</li>
                <li>Existing ones can be more user-friendly</li>
                <li>An effective vaccine will be a powerful tool</li>
                <li>New ecologically safe insecticides are needed to protect homes and treat bed nets</li>
            </ul>
            
            <h4>5. Well-coordinated Strategy</h4>
            <ul>
                <li>Situation Assessment</li>
                <ul>
                    <li>Community prevention and treatment practices will be reviewed and a common strategy built</li>
                </ul>
                <li>Structured Technical Support Networks</li>
                <ul>
                    <li>A network of resource people will be created to provide consistent and harmonized expert advice</li>
                </ul>

            </ul>
            

            <h4>6. Dynamic Movement</h4>
            <ul>
                <li>A Coalition of Stakeholders</li>
                <li>Community Participation</li>
                <ul>
                    <li>The private sector foundations and trusts</li>
                    <li>NGOs Civil societies, Associations, and media</li>
                    <li>UNDP, WB, UNICEF, and key UN Partners</li>
                    <li>Research and Academic institutions</li>
                </ul>
                <li>Involvement of many sectors</li>
            </ul>


            <h4>Targets</h4>
            <ul>
                <li><strong>RBM:</strong> To reduce by Half malaria morbidity and mortality by the year 2010</li>
                <li><strong>SUFI:</strong> Scale-up for Impact (at least 80% coverage for key interventions)</li>
                <li><strong>Universal Coverage:</strong> All households and all susceptible population</li>
                <li><strong>Elimination:</strong></li>
                <li><strong>Eradication:</strong></li>
            </ul>
            
        </div>
      </section>







      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://docs.google.com/forms/d/e/1FAIpQLSdx2teDCmW6ivSeKLQg7zF_jy7Yfg_1Gqm84_UT0PQPATsNug/viewform?usp=sf_link" class="comment-button">
            here
            <!-- <img src="../images/icons/whatsapp.png" alt="Image Icon"> -->
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>

<!-- Floating TOC Button -->
<div id="toc-button" class="floating-toc-button">
  Table of Contents
</div>

<!-- Expandable TOC Panel -->
<div id="toc-panel" class="toc-panel">
  <div id="toc-panel-content">
      <h4>Table of Contents</h4>
      <ol id="dynamic-toc"></ol>
  </div>
</div>



<script>
// Dynamically generate TOC from <h2> headings within <section> elements
  const tocList = document.getElementById('dynamic-toc');
const sections = document.querySelectorAll('section');
const tocButton = document.getElementById('toc-button');
const tocPanel = document.getElementById('toc-panel');

// Generate Table of Contents
sections.forEach(section => {
    const headings = section.querySelectorAll('h2');
    headings.forEach(heading => {
        const headingAnchor = heading.querySelector('a');
        if (headingAnchor && headingAnchor.getAttribute('href')) {
            const tocItem = document.createElement('li');
            const link = document.createElement('a');
            link.textContent = headingAnchor.textContent || 'Untitled Section';
            link.href = headingAnchor.getAttribute('href');
            tocItem.appendChild(link);
            tocList.appendChild(tocItem);
        }
    });
});

// Hide TOC button initially
tocButton.style.display = 'none';

// Show/hide TOC button on scroll
window.addEventListener('scroll', () => {
    // Show button after scrolling down 200 pixels
    if (window.scrollY > 200) {
        tocButton.style.display = 'block';
    } else {
        tocButton.style.display = 'none';
        tocPanel.classList.remove('expanded');
    }
});

// Toggle TOC panel
tocButton.addEventListener('click', (event) => {
    event.stopPropagation(); // Prevent immediate closure
    tocPanel.classList.toggle('expanded');
});

// Close TOC panel when clicking outside
document.addEventListener('click', (event) => {
    if (tocPanel.classList.contains('expanded') && 
        !tocPanel.contains(event.target) && 
        event.target !== tocButton) {
        tocPanel.classList.remove('expanded');
    }
});


</script>

</body>
</html>
 
